Glumetinib
Glumetinib (SCC244) is a highly potent and selective c-Met kinase inhibitor with an IC50 of 0.42 nM. It is widely used in cancer research, demonstrating antitumor activity in both in vitro cellular assays and in vivo xenograft models of c-Met-dependent tumors.
Product Specifications
CAS Number
1642581-63-2
Product Name Alternative
SCC244
Field of Research
Cardiovascular Research
Purity
>98%
Bioactivity
C-Met inhibitor (highly selective)
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
Cn1cc (cn1) -c1cnc2cnn (c2c1) S (=O) (=O) c1cnc2ccc (cn12) -c1cnn (C) c1
Molecular Formula
C21H17N9O2S
Molecular Weight
459.5
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
6- (1-Methylpyrazol-4-yl) -1-[6- (1-methylpyrazol-4-yl) imidazo[1,2-a]pyridine-3-yl]sulfonylpyrazolo[4,3-b]pyridine
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog